LFWD
Lifeward Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$6.98
−1.69%Year over year
Reported trailing growth
- Revenue
- -10.7%
- EBITDA
- -61.9%
- EBIT
- +5.7%
- EPS
- +55.1%
- Free cash flow
- +4.3%
- Operating cash flow
- +4.4%
Forward estimates
Based on analyst estimates
- Revenue
- +60.8%
- EBITDA
- +147.4%
- EPS
- +85.3%
Three-year CAGR
- Revenue
- +58.7%
- EBITDA
- +22.4%
- EBIT
- +13.6%
- Net income
- +31.2%
- EPS
- +57.1%
- Free cash flow
- +22.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026